Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273)
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Interim analysis of original cohorts of Phase 1 […]
Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Read More »









